|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Short MW, Burgers KG and Fry VT:
Esophageal cancer. Am Fam Physician. 95:22–28. 2017.PubMed/NCBI
|
|
3
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song Y, Li L, Ou Y, Gao Z, Li E, Li X,
Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic
alterations in oesophageal squamous cell cancer. Nature. 509:91–95.
2014. View Article : Google Scholar
|
|
5
|
Zhang SW, Zhang M and Li GL: An analysis
of incidence and mortality of esophageal cancer in China,
2003-2007. China Cancer. 4:241–247. 2012.
|
|
6
|
Zhang N, Shi J, Shi X, Chen W and Liu J:
Mutational characterization and potential prognostic biomarkers of
Chinese patients with esophageal squamous cell carcinoma. Onco
Targets Ther. 13:12797–12809. 2020. View Article : Google Scholar
|
|
7
|
Zhong X, Huang G, Ma Q, Liao H, Liu C, Pu
W, Xu L, Cai Y and Guo X: Identification of crucial miRNAs and
genes in esophageal squamous cell carcinoma by miRNA-mRNA
integrated analysis. Medicine (Baltimore). 98:e162692019.
View Article : Google Scholar
|
|
8
|
Liao X, Tang Y, Chattopadhyay SK, Hartley
JW and Morse HC III: Upregulation of Gfi-1, a gene involved in
IL-2-independent growth of T cells, in a murine retrovirus-induced
immunsodeficiency syndrome. In Vivo. 11:9–12. 1997.
|
|
9
|
Cai H, Zhang F and Li Z: Gfi-1 promotes
proliferation of human cervical carcinoma via targeting of FBW7
ubiquitin ligase expression. Cancer Manag Res. 10:2849–2857. 2018.
View Article : Google Scholar
|
|
10
|
Cheng B, Tang S, Zhe N, Ma D, Yu K, Wei D,
Zhou Z, Lu T, Wang J and Fang Q: Low expression of GFI-1 gene is
associated with panobinostat-resistance in acute myeloid leukemia
through influencing the level of HO-1. Biomed Pharmacother.
100:509–520. 2018. View Article : Google Scholar
|
|
11
|
Xian G, Zhao J, Qin C, Zhang Z, Lin Y and
Su Z: Simvastatin attenuates macrophage-mediated gemcitabine
resistance of pancreatic ductal adenocarcinoma by regulating the
TGF-β1/Gfi-1 axis. Cancer Lett. 385:65–74. 2017. View Article : Google Scholar
|
|
12
|
Lee MC, Kuo YY, Chou WC, Hou HA, Hsiao M
and Tien HF: Gfi-1 is the transcriptional repressor of SOCS1 in
acute myeloid leukemia cells. J Leukoc Biol. 95:105–115. 2014.
View Article : Google Scholar
|
|
13
|
Durham GA, Williams JJL, Nasim MT and
Palmer TM: Targeting SOCS proteins to control JAK-STAT signalling
in disease. Trends Pharmacol Sci. 40:298–308. 2019. View Article : Google Scholar
|
|
14
|
Yong YH, Wang P, Jia RM, Gooneratne R,
Robert Wang HC, Liao M and Ju XH: SOCS3 control the activity of
NF-κB induced by HSP70 via degradation of MyD88-adapter-like
protein (Mal) in IPEC-J2 cells. Int J Hyperthermia. 36:151–159.
2019. View Article : Google Scholar
|
|
15
|
Liau NPD, Laktyushin A, Lucet IS, Murphy
JM, Yao S, Whitlock E, Callaghan K, Nicola NA, Kershaw NJ and Babon
JJ: The molecular basis of JAK/STAT inhibition by SOCS1. Nat
Commun. 9:15582018. View Article : Google Scholar
|
|
16
|
Sugase T, Takahashi T, Serada S, Nakatsuka
R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki
Y, et al: Suppressor of cytokine signaling-1 gene therapy induces
potent antitumor effect in patient-derived esophageal squamous cell
carcinoma xenograft mice. Int J Cancer. 140:2608–2621. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sugase T, Takahashi T, Serada S, Fujimoto
M, Hiramatsu K, Ohkawara T, Tanaka K, Miyazaki Y, Makino T,
Kurokawa Y, et al: SOCS1 gene therapy improves radiosensitivity and
enhances irradiation-induced DNA damage in esophageal squamous cell
carcinoma. Cancer Res. 77:6975–6986. 2017. View Article : Google Scholar
|
|
18
|
Amin MB, Gress DM, Meyer Vega LR, et al:
AJCC cancer staging manual. 8th edition. New York: Springer; 2017,
View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Mut M, Amos S and Hussaini IM: PKC alpha
phosphorylates cytosolic NF-kappaB/p65 and PKC delta delays nuclear
translocation of NF-kappaB/p65 in U1242 glioblastoma cells. Turk
Neurosurg. 20:277–285. 2010.
|
|
21
|
Lin HN, Chen LQ, Shang QX, Yuan Y and Yang
YS: A meta-analysis on surgery with or without postoperative
radiotherapy to treat squamous cell esophageal carcinoma. Int J
Surg. 80:184–191. 2020. View Article : Google Scholar
|
|
22
|
Reichenbach ZW, Murray MG, Saxena R,
Farkas D, Karassik EG, Klochkova A, Patel K, Tice C, Hall TM, Gang
J, et al: Clinical and translational advances in esophageal
squamous cell carcinoma. Adv Cancer Res. 144:95–135. 2019.
View Article : Google Scholar
|
|
23
|
Chen J, Yin W, Yao H and Gu W: Salvage
treatment for lymph node recurrence after radical resection of
esophageal squamous cell carcinoma. Radiat Oncol. 14:1692019.
View Article : Google Scholar
|
|
24
|
Duan Z and Horwitz M: Targets of the
transcriptional repressor oncoprotein Gfi-1. Proc Natl Acad Sci
USA. 100:5932–5937. 2003. View Article : Google Scholar
|
|
25
|
Hock H, Hamblen MJ, Rooke HM, Traver D,
Bronson RT, Cameron S and Orkin SH: Intrinsic requirement for zinc
finger transcription factor Gfi-1 in neutrophil differentiation.
Immunity. 18:109–120. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Möröy T and Khandanpour C: Growth factor
independence 1 (Gfi1) as a regulator of lymphocyte development and
activation. Semin Immunol. 23:368–378. 2011. View Article : Google Scholar
|
|
27
|
Grimes HL, Gilks CB, Chan TO, Porter S and
Tsichlis PN: The Gfi-1 protooncoprotein represses Bax expression
and inhibits T-cell death. Proc Natl Acad Sci USA. 93:14569–14573.
1996. View Article : Google Scholar
|
|
28
|
Lin Z, Jiang J and Liu XS: Ursolic
acid-mediated apoptosis of K562 cells involves Stat5/Akt pathway
inhibition through the induction of Gfi-1. Sci Rep. 6:333582016.
View Article : Google Scholar
|
|
29
|
Soliera AR, Mariani SA, Audia A, Lidonnici
MR, Addya S, Ferrari-Amorotti G, Cattelani S, Manzotti G,
Fragliasso V, Peterson L, et al: Gfi-1 inhibits proliferation and
colony formation of p210BCR/ABL-expressing cells via
transcriptional repression of STAT 5 and Mcl-1. Leukemia.
26:1555–1563. 2012. View Article : Google Scholar
|
|
30
|
Yoshimura A, Naka T and Kubo M: SOCS
proteins, cytokine signalling and immune regulation. Nat Rev
Immunol. 7:454–465. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sharma J and Larkin J III: Therapeutic
implication of SOCS1 modulation in the treatment of autoimmunity
and cancer. Front Pharmacol. 10:3242019. View Article : Google Scholar
|
|
32
|
Chen Q, Yin D, Zhang Y, Yu L, Li XD, Zhou
ZJ, Zhou SL, Gao DM, Hu J, Jin C, et al: MicroRNA-29a induces loss
of 5-hydroxymethylcytosine and promotes metastasis of
hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis.
Cell Death Dis. 8:e29062017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Demirel I, Säve S, Kruse R and Persson K:
Expression of suppressor of cytokine signalling 3 (SOCS3) in human
bladder epithelial cells infected with uropathogenic Escherichia
coli. APMIS. 121:158–167. 2013. View Article : Google Scholar
|
|
34
|
Qian Q, Lv Y and Li P: SOCS1 is associated
with clinical progression and acts as an oncogenic role in
triple-negative breast cancer. IUBMB Life. 70:320–327. 2018.
View Article : Google Scholar
|
|
35
|
Gong HL, Tao Y, Mao XZ, Song DY, You D and
Ni JD: MicroRNA-29a suppresses the invasion and migration of
osteosarcoma cells by regulating the SOCS1/NF-κB signalling pathway
through negatively targeting DNMT3B. Int J Mol Med. 44:1219–1232.
2019.PubMed/NCBI
|
|
36
|
Souma Y, Nishida T, Serada S, Iwahori K,
Takahashi T, Fujimoto M, Ripley B, Nakajima K, Miyazaki Y, Mori M,
et al: Antiproliferative effect of SOCS-1 through the suppression
of STAT3 and p38 MAPK activation in gastric cancer cells. Int J
Cancer. 131:1287–1296. 2012. View Article : Google Scholar
|
|
37
|
Chun KS, Jang JH and Kim DH: Perspectives
regarding the intersections between STAT3 and oxidative metabolism
in cancer. Cells. 9:22022020. View Article : Google Scholar
|
|
38
|
Rasmi RR, Sakthivel KM and Guruvayoorappan
C: NF-κB inhibitors in treatment and prevention of lung cancer.
Biomed Pharmacother. 130:1105692020. View Article : Google Scholar
|
|
39
|
Zhao J, Wang X, Mi Z, Jiang X, Sun L,
Zheng B, Wang J, Meng M, Zhang L, Wang Z, et al:
STAT3/miR-135b/NF-κB axis confers aggressiveness and unfavorable
prognosis in non-small-cell lung cancer. Cell Death Dis.
12:4932021. View Article : Google Scholar
|
|
40
|
Cong Y, Cui Y, Zhu S, Cao J, Zou H, Martin
TA, Qiao G, Jiang W and Yu Z: Tim-3 promotes cell aggressiveness
and paclitaxel resistance through NF-κB/STAT3 signalling pathway in
breast cancer cells. Chin J Cancer Res. 32:564–579. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ma J, Yang Y, Fu Y, Guo F, Zhang X, Xiao
S, Zhu W, Huang Z, Zhang J and Chen J: PIAS3-mediated feedback
loops promote chronic colitis-associated malignant transformation.
Theranostics. 8:3022–3037. 2018. View Article : Google Scholar
|
|
42
|
Long L, Pang XX, Lei F, Zhang JS, Wang W,
Liao LD, Xu XE, He JZ, Wu JY, Wu ZY, et al: SLC52A3 expression is
activated by NF-κB p65/Rel-B and serves as a prognostic biomarker
in esophageal cancer. Cell Mol Life Sci. 75:2643–2661. 2018.
View Article : Google Scholar
|
|
43
|
Liu Y, Wang X, Zeng S, Zhang X, Zhao J,
Zhang X, Chen X, Yang W, Yang Y, Dong Z, et al: The natural
polyphenol curcumin induces apoptosis by suppressing STAT3
signaling in esophageal squamous cell carcinoma. J Exp Clin Cancer
Res. 37:3032018. View Article : Google Scholar : PubMed/NCBI
|
